A pan-cancer analysis of copper homeostasis-related gene lipoyltransferase 1: Its potential biological functions and prognosis values

被引:18
|
作者
Liu, Ying [1 ]
Luo, Gengqiu [2 ,3 ]
Yan, Yuanliang [4 ]
Peng, Jinwu [2 ,3 ]
机构
[1] Xiangya Changde Hosp, Dept Pathol, Changde, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Basic Sch Med, Dept Pathol, Changsha, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha, Peoples R China
基金
中国国家自然科学基金;
关键词
LIPT1; pan-cancer; biological functions; prognosis; immune; LIPOYLATION DEFECT; CELL-DEATH; MUTATIONS;
D O I
10.3389/fgene.2022.1038174
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
As a key copper homeostasis-related molecule, lipoyltransferase 1 (LIPT1) is an essential enzyme for the activation of mitochondrial 2-ketoacid dehydrogenase, participating in fatty acylation. However, the biological significances of LIPT1 in the pan-cancer are unclear. Here, we comprehensively analyzed the functional characteristics of LIPT1 in human cancers and its roles in immune response. We found that LIPT1 was down-regulated in some cancers. And LIPT1 overexpression is associated with favorable prognosis in these patients, such as breast cancer, clear cell renal cell carcinoma, ovarian cancer and gastric cancer. We also explored the mutational status and methylation levels of LIPT1 in human cancers. Gene enrichment analysis indicated that abnormally expressed LIPT1 was significantly associated with immune cells infiltration, such as B cells, CD8(+) T cells and cancer-associated fibroblast cells. The result from single cell sequencing reflected the important roles of LIPT1 in the regulation of several biological behaviors of cancer cells, such as DNA damage response and cell apoptosis. Taken together, our research could provide a comprehensive overview about the significances of LIPT1 in human pan-cancer progression, prognosis and immune.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Pan-cancer analysis of DCBLD1 and its association with the diagnosis, immunotherapy, and prognosis of cervical cancer
    Shen, Qilong
    Qiu, Liping
    Zhou, Yinjian
    Wang, Longling
    Pan, Jiewei
    Zhang, Xiaoxing
    Chen, Yun
    Yao, Huaqi
    Wang, Junlin
    Yu, Xieyan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 148
  • [32] Impact of pan-cancer analysis of the exportins family on prognosis, the tumor microenvironment and its potential therapeutic efficacy
    Peng, Ying
    Li, Youheng
    Wang, Lingmei
    Lin, Shenglai
    Xu, Hong
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 25 (01)
  • [33] A pan-cancer analysis of collagen VI family on prognosis, tumor microenvironment, and its potential therapeutic effect
    Li, Xiang
    Li, Zeng
    Gu, Shanzhi
    Zhao, Xinhan
    BMC BIOINFORMATICS, 2022, 23 (01)
  • [34] A pan-cancer analysis of collagen VI family on prognosis, tumor microenvironment, and its potential therapeutic effect
    Xiang Li
    Zeng Li
    Shanzhi Gu
    Xinhan Zhao
    BMC Bioinformatics, 23
  • [35] DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis
    Yuan, Ziming
    Zhong, Yuchen
    Hu, Hanqing
    Zhang, Weiyuan
    Wang, Guiyu
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [36] A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets
    Wu, Shaobo
    Zang, Qijuan
    Xing, Zixuan
    Li, Xiang
    Leng, Jing
    Liu, Yanbing
    Wang, Xiaofei
    Yang, Juan
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2021, 31 (04): : 35 - 48
  • [37] Gelsolin: A comprehensive pan-cancer analysis of potential prognosis, diagnostic, and immune biomarkers
    Wang, Yiyang
    Bi, Xiaojuan
    Luo, Zhiwen
    Wang, Haiyan
    Ismtula, Dilimulati
    Guo, Chenming
    FRONTIERS IN GENETICS, 2023, 14
  • [38] Pan-cancer analysis of FBXW family with potential implications in prognosis and immune infiltration
    Huang, Tingting
    OuYang, XIaoxiao
    Li, Jiwei
    Shi, Bingbing
    Shan, Zhengda
    Shi, Zhiyuan
    Yang, Zhangru
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [39] Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis
    Ye, Yingquan
    Jiang, Haili
    Wu, Yue
    Wang, Gaoxiang
    Huang, Yi
    Sun, Weijie
    Zhang, Mei
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [40] Pan-cancer analysis of transcripts encoding novel open-reading frames (nORFs) and their potential biological functions
    Erady, Chaitanya
    Boxall, Adam
    Puntambekar, Shraddha
    Suhas Jagannathan, N.
    Chauhan, Ruchi
    Chong, David
    Meena, Narendra
    Kulkarni, Apurv
    Kasabe, Bhagyashri
    Prathivadi Bhayankaram, Kethaki
    Umrania, Yagnesh
    Andreani, Adam
    Nel, Jean
    Wayland, Matthew T.
    Pina, Cristina
    Lilley, Kathryn S.
    Prabakaran, Sudhakaran
    NPJ GENOMIC MEDICINE, 2021, 6 (01)